https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-04-01 / Biol. Chem. 2001 Apr;382(4):507-20
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-04-01 / Biol. Chem. 2001 Apr;382(4):507-202001-04-01 00:00:002019-02-15 08:44:55Dendritic cells for specific cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-02-01 / Cancer Res. 2001 Feb;61(3):842-7
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-02-01 / Cancer Res. 2001 Feb;61(3):842-72001-02-01 00:00:002019-02-15 08:47:03Vaccination of malignant glioma patients with peptide-pulsed dendritic cells elicits systemic cytotoxicity and intracranial T-cell infiltration
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / J. Cancer Res. Clin. Oncol. 2001;127(3):203-6
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / J. Cancer Res. Clin. Oncol. 2001;127(3):203-62001-01-01 00:00:002019-02-15 08:53:39In vitro induction of a bladder cancer-specific T-cell response by mRNA-transfected dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Exp. Hematol. 2001 Jan;29(1):85-922001-01-01 00:00:002019-02-15 08:51:14Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2001-01-01 / Clin. Cancer Res. 2001 Jan;7(1):23-31
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2001-01-01 / Clin. Cancer Res. 2001 Jan;7(1):23-312001-01-01 00:00:002019-02-15 08:53:40Immunotherapy of bladder cancer using autologous dendritic cells pulsed with human lymphocyte antigen-A24-specific MAGE-3 peptide
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-12-15 / Neurosurg Focus 2000 Dec;9(6):e8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-12-15 / Neurosurg Focus 2000 Dec;9(6):e82000-12-15 00:00:002019-02-15 08:46:54Treatment of a patient by vaccination with autologous dendritic cells pulsed with allogeneic major histocompatibility complex class I-matched tumor peptides. Case Report
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-11-01 / Blood 2000 Nov;96(9):3102-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-11-01 / Blood 2000 Nov;96(9):3102-82000-11-01 00:00:002000-11-01 00:00:00Induction of cytotoxic T-lymphocyte responses in vivo after vaccinations with peptide-pulsed dendritic cells
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-03-01 / Br. J. Haematol. 2000 Mar;108(4):805-16
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-03-01 / Br. J. Haematol. 2000 Mar;108(4):805-162000-03-01 00:00:002019-02-15 08:51:14Vaccination of multiple myeloma patients with idiotype-pulsed dendritic cells: immunological and clinical aspects
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Curr. Opin. Mol. Ther. 2000 Feb;2(1):20-8
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Curr. Opin. Mol. Ther. 2000 Feb;2(1):20-82000-02-01 00:00:002019-02-15 08:45:17Clinical applications of dendritic cell vaccines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-15
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2000-02-01 / Med. Oncol. 2000 Feb;17(1):2-152000-02-01 00:00:002019-02-15 08:51:15Dendritic cell biology and the application of dendritic cells to immunotherapy of multiple myeloma
